Filter posts

Expanding Access to Orphan Drugs

At present many orphan diseases do not have any licensed treatments, and for those conditions …

Our Health Care Ecosystem

There are currently 907 drugs and vaccines targeting more than 100 diseases in development by …

Approving Drugs for Alzheimer’s Disease

BIOtechNOW delves into the current state of Alzheimer’s disease research with today’s feature on regulatory …

Patients are the Missing Link in R&D

An architect does not wait until construction begins to show clients a blueprint. Neither does a caterer …

Cranial Connections: Ontario’s Brain Research is Hardwired for Success

Ontario has long been a leader in life sciences research and technology with brain exploration …

Psoriasis Patients Flock to Social Media for Practical Info

About eight in 10 psoriasis patients who use health care social networks say they do …

The Michael J. Fox Foundation Launches New Funding Opportunities

The Michael J. Fox Foundation (MJFF) is committed to sharing the risk of drug development …

A Bright Future for Orphan Disease Indications

In celebration of National Rare Disease Day BIO’s Industry Analysis team took a look at recently-approved …

Navigating the Rare Disease World

The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled …

Rare Disease Day: Families and Advocacy Groups Drive Treatments for Rare Diseases

Today, we celebrate Rare Disease Day to recognize the path to treatments and cures is …